Our pooled results demonstrated a negative trend of PCa risk with more than four years of aspirin use.
← all excerpts
Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
1
—
—